Blue Shield of California is one of 17 major health plans that has committed to adopting payment models inspired by the Medicare Innovation Center’s ACCESS Model.
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.
Though I have treated thousands of patients since, Nov. 6, 2022 — the day of a record hot New York City Marathon — still ...
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...
Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.
A final Medicare rule aimed at lowering prices for doctor-administered drugs applies to only four companies and saves 96% less than the initial proposal ...
A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech ...
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.
Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results